6:09 PM
 | 
Feb 22, 2010
 |  BC Extra  |  Politics & Policy

Obama's bill has biosimilars, increased fees

President Obama Monday released a summary of healthcare reform legislation that would create a pathway for biosimilars. The White House bill is based on the Senate healthcare reform bill, which would provide 12 years...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >